Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/803
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBrown, Gregor-
dc.contributor.authorMoss, Alan-
dc.contributor.otherBahin, F. F.-
dc.contributor.otherRasouli, K. N.-
dc.contributor.otherByth, Karen-
dc.contributor.otherHourigan, Luke-
dc.contributor.otherSingh, Rajvinder-
dc.contributor.otherZanati, Simon-
dc.contributor.otherRaftopoulos, Spiro-
dc.contributor.otherWilliams, Scott-
dc.contributor.otherBourke, Michael-
dc.date2016-06-
dc.date.accessioned2016-09-16T04:03:05Z-
dc.date.available2016-09-16T04:03:05Z-
dc.date.issued2016-08-
dc.identifier.citationAm J Gastroenterol. 2016 Aug;111(8):1115-22en_US
dc.identifier.issn0002-9270en_US
dc.identifier.issn1572-0241en_US
dc.identifier.urihttp://hdl.handle.net/11434/803-
dc.description.abstractOBJECTIVES: Clinically significant bleeding (CSPEB) is the most frequent adverse event following wide-field endoscopic mucosal resection (WF-EMR) of large sessile and laterally spreading colorectal lesions (LSL). There is limited knowledge regarding accurate prediction of CSPEB. We aimed to derive a score to predict the risk of CSPEB. METHODS: Data on patient and lesion characteristics and outcomes from WF-EMRs of LSL ≥20 mm at 8 referral hospitals were analyzed. The cohort was divided at random into equal sized training and test groups. Independent predictors of CSPEB in the training cohort were identified by multiple logistic regression analysis and used to develop a risk score. The performance of this score was assessed in the independent test cohort. RESULTS: Over 80 months to June 2015, 2,128 patients with 2,424 LSL were referred for WF-EMR. Two thousand and twelve patients were eligible for analysis. There were 135 cases of CSPEB (6.7%). In the training cohort of 1,006 patients, the independent predictors of CSPEB were lesion size >30 mm (odds ratio (OR) 2.5), proximal colonic location (OR 2.3), presence of a major comorbidity (OR 1.5), and epinephrine in injection solution (OR 0.57). The derived risk score comprised lesion size >30 mm (2 points), proximal colon (2 points), presence of major comorbidity (1 point), and absence of epinephrine use (1 point). The probabilities of CSPEB for scores of 0, 1, 2, 3, 4, and ≥5 in the training cohort were 1.5, 2.0, 5.6, 7.8, 9.1, and 17.5% and were 0.9, 6.7, 4.9, 6.2, 9.0, and 15.7% in the test cohort. The probabilities of CSPEB in those with low (score 0-1), medium (score 2-4), and elevated (score 5-6) risk levels were 1.7, 7.1, and 17.5% in the training cohort and 3.4, 6.2, and 15.7% in the test cohort. CONCLUSIONS: Patients at elevated risk of CSPEB can be identified using four readily available variables. This knowledge may improve the management of those undergoing WF-EMR and assist in designing studies evaluating CSPEB.en_US
dc.publisherNature Publishing Groupen_US
dc.subjectClinically Significant Bleedingen_US
dc.subjectCSPEBen_US
dc.subjectWide-Field Endoscopic Mucosal Resectionen_US
dc.subjectWF-EMRen_US
dc.subjectLaterally Spreading Colorectal Lesionsen_US
dc.subjectLSLen_US
dc.subjectMultiple Logistic Regression Analysisen_US
dc.titlePrediction of clinically significant bleeding following wide-field endoscopic resection of large sessile and laterally spreading colorectal lesions: A clinical risk score.en_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1038/ajg.2016.235en_US
dc.identifier.journaltitleThe American Journal of Gastroenterologyen_US
dc.description.pubmedurihttp://www.ncbi.nlm.nih.gov/pubmed/27296942en_US
dc.description.affiliatesDepartment of Gastroenterology and Hepatology, Westmead Hospital, Sydney, Australia.en_US
dc.description.affiliatesWestmead Clinical School, University of Sydney, Sydney, Australia.en_US
dc.description.affiliatesSydney Medical School NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.en_US
dc.description.affiliatesResearch and Education Network, Westmead Hospital, Sydney, Australia.en_US
dc.description.affiliatesDepartment of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, Australia.en_US
dc.description.affiliatesGreenslopes Private Hospital, Brisbane, Australia.en_US
dc.description.affiliatesDepartment of Gastroenterology and Hepatology, Lyell McEwin Hospital, Adelaide, Australia.en_US
dc.description.affiliatesDepartment of Gastroenterology and Hepatology, The Alfred Hospital, Melbourne, Australia.en_US
dc.description.affiliatesDepartment of Gastroenterology and Hepatology, Western Health, Melbourne, Australia.en_US
dc.description.affiliatesDepartment of Gastroenterology and Hepatology, Sir Charles Gairdner Hospital, Perth, Australia.en_US
dc.type.studyortrialRetrospective studiesen_US
dc.type.contenttypeTexten_US
Appears in Collections:Cancer Services
General Surgery and Gastroenterology

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.